Related Experiment Video
Updated: Jun 26, 2025
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
10.9K
The association between polyunsaturated fatty acids and chronic obstructive pulmonary disease: a meta-analysis
Zhe Piao1, Bowen Chai2, Yuxiao Wu3
1Department of Neurology, China-Japan Union Hospital, Jilin University, Changchun, 130021, P. R. China.
Food & Function
|May 13, 2024
Summary
Polyunsaturated fatty acids (PUFAs) intake is lower in COPD patients. Lower n-3 PUFA and higher n-6 PUFA levels increase COPD risk, suggesting a link between PUFAs and this respiratory disease.
Area of Science:
- Nutritional Science
- Respiratory Medicine
- Biochemistry
Background:
- Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory condition influenced by nutritional factors.
- The specific role of polyunsaturated fatty acids (PUFAs) in COPD development and prognosis requires clarification.
Purpose of the Study:
- To investigate the association between polyunsaturated fatty acids (PUFAs) and chronic obstructive pulmonary disease (COPD).
- To evaluate differences in PUFA levels between COPD patients and controls.
- To assess the risk of COPD associated with varying PUFA concentrations and the impact of PUFA supplementation.
Main Methods:
- A comprehensive literature search was conducted across electronic databases up to October 2023.
- Meta-analysis was employed to synthesize data from nineteen eligible studies involving 155,636 subjects.
- Evaluated dietary intake, blood levels of n-3 and n-6 PUFAs, and effects of PUFA supplementation on COPD.
Main Results:
- COPD patients exhibited lower daily dietary intake of polyunsaturated fatty acids (PUFAs) compared to controls.
- Reduced levels of n-3 PUFAs and elevated levels of n-6 PUFAs were significantly associated with an increased risk of COPD.
- PUFA supplementation showed a trend towards increased low-density lipoprotein cholesterol, though not statistically significant in this meta-analysis.
Conclusions:
- The meta-analysis suggests a potential link between polyunsaturated fatty acids (PUFAs) and chronic obstructive pulmonary disease (COPD).
- Further large-scale prospective cohort studies and clinical trials are warranted to confirm these findings and elucidate the precise relationship.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
01:22Chronic Obstructive Pulmonary Disease
1.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K